| Literature DB >> 16504165 |
Caroline H G Bastiaenen1, Rob A de Bie, Pieter M J C Wolters, Johan W S Vlaeyen, Pieter Leffers, Foekje Stelma, Janneke M Bastiaanssen, Gerard G M Essed, Piet A van den Brandt.
Abstract
BACKGROUND: For the moment, scientific evaluation of programs on treatment of pregnancy-related pelvic girdle and/or low back pain after delivery is hardly available with only one study with a positive result, suggesting uncertainty about the optimal approach. Investigators draw particular attention to biomedical factors but there is growing evidence that biopsychosocial factors appear to be even more important as a basis of an intervention program.Entities:
Mesh:
Year: 2006 PMID: 16504165 PMCID: PMC1420299 DOI: 10.1186/1471-2474-7-19
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Timing of measures
| Baseline (about 3 weeks after delivery) | 12 weeks after randomization | |
| Baseline | ||
| History taking | X | |
| Physical | ||
| Examination: | X | |
| PBS | X | |
| Expectancy treatment result | X | |
| PCS | X | |
| BDI | X | |
| NEM | X | |
| PEM | X | |
| Primary outcomes | ||
| RDQ | X | X |
| MC | X | X |
| GPE | X | X |
| Secondary outcomes | ||
| MPQ(VAS) | X | X |
| TSK | X | X |
| SF-36 | X | X |
| IPA | X | X |
| Compliance | X | |
| Co-intervention | X | |
| Medication | X | |
| Additional medical consumption | X | |
| Contents treatment | X |
PBS = Pain Behavior Scale
GPE = Global Perceived Effect
MC = Main Complaint
MPQ = McGill Pain Questionnaire
RDQ = Roland Disability Questionnaire
TSK = Tampa Scale For Kinesiophobia
PCS = Pain Catastrophizing Scale
BDI = Beck Depression Inventory
NEM = Negative Emotionality Scale
PEM = Positive Emotionality Scale
SF-36 = Short-Form-36
IPA = Impact on Participation and Autonomy
Figure 1Flowchart of participants through the study.
Baseline characteristics and measures according to treatment group
| Variable | Usual Care n = 64 | Experimental Intervention n = 62 |
| Age (SD) | 31.5 (3.1) | 31.4 (3.6) |
| Localization of pain: (n/%) | ||
| Lumbar spine | 25 (39.1) | 24 (38.7) |
| SI joints (one or two) | 34 (53.1) | 34 (54.8) |
| Symphysis | 43 (67.2) | 42 (67.7) |
| History of LB/PG pain ⌂ (n/%) | 43 (67.2) | 44 (71.0) |
| Parity (SD) | 2.1 (1.0) | 2.3 (1.0) |
| Measures (SD) | ||
| VAS (pain today) (0–100) | 54.3 (17.5) | 53.5 (19.1) |
| VAS (pain this week) (0–100) | 59.2 (17.9) | 57.0 (17.8) |
| RDQ (0–24) | 13.5 (4.3) | 13.3 (4.6) |
| IPA: | ||
| Autonomy in self-care (0–28) | 9.6 (5.7) | 8.8 (5.1) |
| Mobility and leisure (0–20) | 10.9 (3.7) | 10.0 (4.7) |
| Family role (0–28) | 15.4 (5.8) | 14.4 (5.6) |
| Social relationships (0–24) | 5.8 (3.3) | 5.5 (3.4) |
| MC (VAS)□ (0–100) | 69.5 (17.5) | 72.0 (15.7) |
| TSK: | ||
| Total score (17–68) | 35.7 (5.9) | 32.9 (5.0) |
| Fear avoidance ▶(8–32) | 18.8 (3.6) | 17.0 (3.0) |
| Harm▲ (5–20) | 8.5 (2.2) | 7.9 (2.3) |
| PCS (0–52) | 12.2 (9.8) | 11.2 (8.4) |
| BDI ■ (0–54) | 5.3 (4.9) | 5.1 (4.2) |
| NEM (0–14) | 3.3 (3.4) | 2.4 (2.3) |
| PEM (0–11) | 7.8 (2.6) | 8.5 (2.4) |
| SF-36: | ||
| General health (0–100) | 54.6 (12.5) | 57.8 (13.1) |
| Expectancy treatment (0–100) | 79.0 (17.8) | 78.3 (16.6) |
| PBS◀ (0–8) | 1.3 (1.3) | 1.5 (1.6) |
■ mean BDI calculated without items 15,16,19
□ first main complaint (MC) was selected
▶TSK subscale fear avoidance (items 1,2,9,10,13,14,15,17)
▲TSK subscale harm (items 3,5,6,7,11)
◀ Pain behavior Scale filled out by research -physiotherapist after physical examination
⌂ LB /PG pain = low back and/or pregnancy-related pelvic girdle pain
Outcomes, mean change and differences between groups in outcome measures
| Outcome measure | Outcome Usual Care N = 56 Mean SD | Outcome Experimental Intervention N = 58 Mean SD | Mean Change Usual Care N = 56 Mean SD | Mean change Experimental Intervention N = 58 Mean SD | Differences between groups Mean (95% CI) P-value |
| Primary outcomes | |||||
| RDQ (0–24) | 6.8 (5.5) | 4.5 (4.9) | 6.7 (4.9) | 8.7 (5.8) | -2.0 {-4.0;0.0} 0.05 |
| MC (VAS) (0–100)* | 26.8 (21.0) | 21.0 (21.9) | 41.5 (29.3) | 50.8 (24.9) | -9.3 {-19.4;0.7} 0.07 |
| GPE n / %# | 37 (66.1) | 43 (74.1) | -8 % {-24.2;8.2} 0.34 | ||
| Secondary outcomes | |||||
| VAS (pain today)(0–100) | 26.3 (19.9) | 24.3 (24.1) | 26.7 (22.5) | 27.7 (25.4) | -1.0 {-9.9;7.9} 0.83 |
| VAS (pain this week)(0–100) | 29.6 (21.7) | 25.3 (23.0) | 29.2 (24.8) | 30.3 (27.0) | -1.1 {-10.7;8.5} 0.82 |
| IPA: | |||||
| Autonomy in self-care(0–28) | 4.0 (4.6) | 3.0 (4.3) | 5.8 (5.1) | 5.7 (5.4) | 0.06 {-1.9;2.0} 0.95 |
| Mobility and leisure (0–20) | 6.3 (4.0) | 5.6 (4.4) | 4.6 (3.6) | 4.4 (4.8) | 0.14 {-1.5;1.8} 0.87 |
| Family role (0–28) | 9.2 (5.1) | 7.8 (5.8) | 6.3 (5.8) | 6.3 (5.5) | 0.04 {-2.1;2.1} 0.93 |
| Social relationships (0–24) | 4.4 (2.9) | 4.0 (3.3) | 1.0 (2.7) | 1.5 (2.5) | -0.43 {-1.4;0.6} 0.39 |
| TSK: | |||||
| Total score (17–68) | 32.4 (5.6) | 28.6 (6.0) | 3.5 (5.8) | 4.4 (5.8) | -0.9 {-3.0;1.3} 0.42 |
| Fear Avoidance † (8–32) | 16.2 (3.7) | 13.5 (4.0) | 2.6 (3.7) | 3.5 (3.7) | -0.83 {-2.2;0.6} 0.24 |
| Harm (5–20)‡ | 7.9 (2.4) | 7.2 (2.3) | 0.8 (6.0) | 0.7 (2.2) | 0.03 {--0.85;0.9} 0.95 |
| SF 36: | |||||
| General health (0–100) | 59.2 (13.7) | 61.4 (14.0) | 3.7 (13.8) | 3.4 (9.5) | -0.39 {-4.8;4.0} 0.86 |
* First main complaint (MC) was selected, † TSK subscale fear avoidance (items 1,2 9, 10, 13, 14, 15, 17), ‡ TSK subscale harm (items 3, 5, 6, 7, 11), # ratings on a 7-point scale are dichotomized as improved (completely recovered and much improved) and not-improved (Slightly improved, not changed and slightly/ much/ vastly worsened)
Subgroup analyses primary outcomes
| Outcome measure | Outcome Usual Care Mean SD | Outcome Experimental intervention Mean SD | Mean change Usual Care Mean SD | Mean change experimental intervention Mean SD | Differences between groups Mean 95% P-value |
| Subgroup RDQ baseline < 13 | |||||
| N | 22 | 25 | |||
| Primary outcomes | |||||
| RDQ (0–24) | 3.8 (3.0) | 3.8 (3.6) | 5.7 (3.4) | 5.7 (4.5) | 0.0002 {-2.4;2.3} 0.99 |
| MC (VAS) (0–100) * | 23.4 (23.5) | 18.5 (19.3) | 46.7 (30.0) | 50.4 (19.5) | -3.3 {-17.9;11.4} 0.65 |
| GPE n/ %# | 16 (72.7) | 20 (80.0) | -7.3 {-30.8;23.5} 0.55 | ||
| Subgroup RDQ baseline ≥ 13 | |||||
| N | 34 | 33 | |||
| Primary outcomes | |||||
| RDQ (0–24) | 8.7 (5.9) | 5.5 (5.5) | 6.4 (5.8) | 10.7 (6.0) | -4.3 {-7.0;-1.5} 0.003 |
| MC (VAS) (0–100) * | 29.0 (19.2) | 22.9 (24.7) | 38.0 (28.9) | 51.5 (28.5) | -13.4 {-27.4;0.6} 0.06 |
| GPE n/ %# | 21 (61.8) | 23 (69.8) | -8.0 {-22.5;14.6} 0.49 |
* First main complaint (MC) was selected, # ratings on a 7-point scale are dichotomized as improved (completely recovered and much improved) and not-improved (Slightly improved, not changed and slightly/ much/ vastly worsened)